医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.

广告
第一作者: Vincent D,de Jager
第一单位: Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
作者单位: Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. [1] Oncostat U1018, Inserm, Paris-Saclay University, Gustave Roussy, Villejuif, France. [2] Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy of University of Gothenburg, Gothenburg, Sweden. [3] Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria. [4] Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany. [5] Pulmonology Department, Centro Hospitalar Universitário de São João, Porto, Portugal. [6] Charles University and Thomayer Hospital, Prague, Czech Republic. [7] Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.;Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria. [8] IHU RespirERA, FHU OncoAge, Nice University Hospital, Côte d'Azur University, Nice, France. [9] Department of Oncology, University Hospital Antwerp, University of Antwerp, Edegem, Belgium. [10] Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. [11] Department of Pathology, University Hospital Antwerp, University of Antwerp, Edegem, Belgium. [12] Laboratory for Cytology and Pathology, University Clinic Golnik, Golnik, Slovenia. [13] Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i+12), Ciberonc, Madrid, Spain. [14] National Disease Registration Service, NHS England, London, United Kingdom.;Centre for Cancer, Society & Public Health, King's College London, London, United Kingdom. [15] Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.;Faculty of Medicine of the University of Porto, Institute for Research and Innovation in Health (i3S), Porto, Portugal. [16] University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. [17] Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, H12O-CNIO Lung Cancer Clinical Research Unit, Research Institute Hospital 12 de Octubre (i+12)/Spanish National Cancer Research Center (CNIO), Ciberonc, Madrid, Spain. [18] Lung Unit, Royal Marsden NHS Trust, London, United Kingdom. [19] The Fingerland Department of Pathology, Charles University Medical Faculty and University Hospital, Czech Republic. [20] Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. [21] Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany. [22] Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. [23]
DOI 10.1016/j.lanepe.2024.100838
PMID 38476742
发布时间 2024-10-31
提交
  • 浏览1
The Lancet regional health. Europe

The Lancet regional health. Europe

2024年38卷

100838页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷